Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer

Journal of Molecular Endocrinology

Volumn 50, Issue 2, 2013, Pages 179-191

  Seim, Inge ^a   Lubik, Amy A ^a,b   Lehman, Melanie L ^a,b   Tomlinson, Nadine ^b   Whiteside, Eliza J ^a   Herington, Adrian C ^a   Nelson, Colleen C ^a,b   Chopin, Lisa K ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b VANCOUVER PROSTATE CENTRE   (Canada)

Author keywords

Cancer; Cryptic exon; Ghrelin; Insulin; Prostate; Splicing; Testis

Indexed keywords

AMINO ACID; GHRELIN; INSULIN;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GROWTH; CANCER RISK; CASTRATION RESISTANT PROSTATE CANCER; CELL STRAIN LNCAP; CONTROLLED STUDY; EXON; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INTRON; METABOLIC SYNDROME X; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS; TRANSCRIPTION REGULATION; UPREGULATION;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ORDER; GENETIC LOCI; GHRELIN; HUMANS; INSULIN; MALE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PROSTATIC NEOPLASMS; RNA SPLICING; SEQUENCE ALIGNMENT;

EID: 84874084911     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0150     Document Type: Article

References (93)

1. Aggarwal RR, Ryan CJ & Chan JM 2013 Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? Urologic Oncology. In press. (doi:10.1016/j.urolonc.2011.05.001)
2. Amling CL 2005 Relationship between obesity and prostate cancer. Current Opinion in Urology 15 167-171. (doi:10.1097/01.mou.0000165550. 94663.fb)
3. Baatar D, Patel K & Taub DD 2011 The effects of ghrelin on inflammation and the immune system. Molecular and Cellular Endocrinology 340 44-58. (doi:10.1016/j.mce.2011.04.019)
4. Bang AS, Soule SG, Yandle TG, Richards AM & Pemberton CJ 2007 Characterisation of proghrelin peptides in mammalian tissue and plasma. Journal of Endocrinology 192 313-323. (doi:10.1677/JOE-06-0021)
5. Bao Y, Nimptsch K, Wolpin BM, Michaud DS, Brand-Miller JC, Willett WC, Giovannucci E & Fuchs CS 2011 Dietary insulin load, dietary insulin index, and risk of pancreatic cancer. American Journal of Clinical Nutrition 94 862-868. (doi:10.3945/ajcn.110.011205)
6. Beaumont NJ, Skinner VO, Tan TM, Ramesh BS, Byrne DJ, MacColl GS, Keen JN, Bouloux PM, Mikhailidis DP, Bruckdorfer KR et al. 2003 Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. Journal of Biological Chemistry 278 8877-8880. (doi:10.1074/jbc.C200575200)
7. Burset M, Seledtsov IA & Solovyev VV 2000 Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Research 28 4364-4375. (doi:10.1093/nar/28.21.4364)
8. Buschemeyer WC III & Freedland SJ 2007 Obesity and prostate cancer: epidemiology and clinical implications. European Urology 52 331-343. (doi:10.1016/j.eururo.2007.04.069)
9. Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E & Muccioli G 2001 Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. Journal of Clinical Endocrinology and Metabolism 86 1738-1745. (doi:10.1210/jc.86.4.1738)
10. Cassoni P, Ghe C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M & Muccioli G 2004 Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. European Journal of Endocrinology 150 173-184. (doi:10.1530/eje.0.1500173)
11. Chopin L, Walpole C, Seim I, Cunningham P, Murray R, Whiteside E, Josh P & Herington A 2011 Ghrelin and cancer. Molecular and Cellular Endocrinology 340 65-69. (doi:10.1016/j.mce.2011.04.013)
12. Chopin LK, Seim I, Walpole CM & Herington AC 2012 The ghrelin axis-does it have an appetite for cancer progression? Endocrine Reviews 33 849-891. (doi:10.1210/er.2011-1007)
13. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, Williams A & Blume JE 2007 Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biology 8 R64. (doi:10.1186/gb-2007-8-4-r64)
14. Date Y, Kojima M, Hosada H, Sawaguchi A, Mondal M, Suganama T, Matsukura S, Kangawa K & Nakazato M 2000 Ghrelin, a novel growth hormone releasing acylated peptide is synthesised in a distinct endocrine cell type in gastrointestinal tracts of rats and humans. Endocrinology 141 4255-4261. (doi:10.1210/en.141.11.4255)
15. Deboer MD 2011 Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes? Molecular and Cellular Endocrinology 340 97-105. (doi:10.1016/j.mce.2011.02.012)
16. De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P & Delporte C 2004 Ghrelin degradation by serum and tissue homogen-ates: identification of the cleavage sites. Endocrinology 145 4997-5005. (doi:10.1210/en.2004-0569)
17. Diaz-Lezama N, Hernandez-Elvira M, Sandoval A, Monroy A, Felix R & Monjaraz E 2010 Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells. Biochemical and Biophysical Research Communications 403 24-29. (doi:10.1016/j.bbrc.2010.10.100)
18. Eubanks LM, Stowe GN, DeLamoMarin S, Mayorov AV, Hixon MS & Janda KD 2011 Identification of a2 macroglobulin as a major serum ghrelin esterase. Angewandte Chemie (International ed.) 50 10699-10702. (doi:10.1002/anie.201104512)
19. Fick LJ, Cai F & Belsham DD 2009 Hypothalamic preproghrelin gene expression is repressed by insulin via both PI3-K/Akt and ERK1/2 MAPK pathways in immortalized, hypothalamic neurons. Neuroendocrinology 89 267-275. (doi:10.1159/000167698)
20. French PJ, Peeters J, Horsman S, Duijm E, Siccama I, van den Bent MJ, Luider TM, Kros JM, van der Spek P & Sillevis Smitt PA 2007 Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Research 67 5635-5642. (doi:10.1158/0008-5472.CAN-06-2869)
21. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A et al. 2011 The UCSC Genome Browser database: update 2011. Nucleic Acids Research 39 D876-D882. (doi:10.1093/nar/gkq963)
22. Gahete MD, Rubio A, Cordoba-Chacon J, Gracia-Navarro F, Kineman RD, Avila J, Luque RM & Castano JP 2010 Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. Journal of Alzheimer's Disease 22 819-828. (doi:10.3233/JAD-2010-100873)
23. Gahete MD, Cordoba-Chacon J, Hergueta-Redondo M, Mart́inez-Fuentes AJ, Kineman RD, Moreno-Bueno G, Luque RM & Castano JP 2011 A novel human ghrelin variant (in1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. PLoS ONE 6 e23302. (doi:10.1371/journal.pone.0023302)
24. Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, Pinilla L, Paniagua R, Nistal M, Casanueva FF et al. 2004 Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. Journal of Clinical Endocrinology and Metabolism 89 400-409. (doi:10.1210/jc.2003-031375)
25. Gnanapavan S, Kola B, Bustin S, Morris D, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman A & Korbonits M 2002 The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism 87 2988. (doi:10.1210/jc.87.6.2988)
26. Granata R, Baragli A, Settanni F, Scarlatti F & Ghigo E 2010 Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. Journal of Molecular Endocrinology 45 107-118. (doi:10.1677/JME-10-0019)
27. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL et al. 2009 Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 101 48-60. (doi:10.1093/jnci/djn415)
28. Gurriaran-Rodriguez U, Al-Massadi O, Crujeiras AB, Mosteiro CS, Amil-Diz M, Beiroa D, Nogueiras R, Seoane LM, Gallego R, Pazos Y et al. 2011 Preproghrelin expression is a key target for insulin action on adipogenesis. Journal of Endocrinology 210 R1-R7. (doi:10.1530/JOE-11-0233)
29. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE & Hale JE 2008 Ghrelin octanoylation mediated by an orphan lipid transferase. PNAS 105 6320-6325. (doi:10.1073/pnas.0800708105)
30. Hammarsten J & Hogstedt B 2005 Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. European Journal of Cancer 41 2887-2895. (doi:10.1016/j.ejca.2005.09.003)
31. Hammarsten J & Peeker R 2011 Urological aspects of the metabolic syndrome. Nature Reviews. Urology 8 483-494. (doi:10.1038/nrurol. 2011.112)
32. Hammarsten J, Damber JE, Peeker R, Mellstrom D & Hogstedt B 2010 A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer. Cancer Epidemiology 34 574-579. (doi:10.1016/j.canep.2010.06.014)
33. Hartmann B, Castelo R, Blanchette M, Boue S, Rio DC & Valcarcel J 2009 Global analysis of alternative splicing regulation by insulin and wingless signaling in Drosophila cells. Genome Biology 10 R11. (doi:10.1186/gb-2009-10-1-r11)
34. He C, Zhou F, Zuo Z, Cheng H & Zhou R 2009 A global view of cancer-specific transcript variants by subtractive transcriptome-wide analysis. PLoS ONE 4 e4732. (doi:10.1371/journal.pone.0004732)
35. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E & Reynolds JV 2010 Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clinical Oncology 22 281-288. (doi:10.1016/j.clon.2010.02.001)
36. Holmes E, Davies I, Lowe G & Ranganath LR 2009 Circulating ghrelin exists in both lipoprotein bound and free forms. Annals of Clinical Biochemistry 46 514-516. (doi:10.1258/acb.2009.008254)
37. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F & Kangawa K 2004 Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clinical Chemistry 50 1077-1080. (doi:10.1373/clinchem.2003.025841)
38. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 974-977. (doi:10.1126/science.273.5277.974)
39. Isgaard J & Granata R 2011 Ghrelin in cardiovascular disease and atherogenesis. Molecular and Cellular Endocrinology 340 59-64. (doi:10.1016/j.mce.2011.03.006)
40. Ishikawa T, Fujioka H, Ishimura T, Takenaka A & Fujisawa M 2007 Ghrelin expression in human testis and serum testosterone level. Journal of Andrology 28 320-324. (doi:10.2164/jandrol.106.000810)
41. Jeffery PL, Herington AC & Chopin LK 2002 Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. Journal of Endocrinology 172 R7-R11. (doi:10.1677/ joe.0.172R007)
42. Jeffery P, Murray R, Yeh A, McNamara J, Duncan RP, Francis G, Herington A & Chopin L 2005 Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocrine-Related Cancer 12 839-850. (doi:10.1677/erc.1.00984)
43. Jeffery P, McDonald V, Tippett E & McGuckin M 2011 Ghrelin in gastrointestinal disease. Molecular and Cellular Endocrinology 340 35-43. (doi:10.1016/j.mce.2011.03.002)
44. Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S & Madden TL 2008 NCBI BLAST: a better web interface. Nucleic Acids Research 36 W5-W9. (doi:10.1093/nar/gkn201)
45. Kineman RD, Gahete MD & Luque RM 2007 Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. Journal of Molecular Endocrinology 38 511-521. (doi:10.1677/JME-06-0026)
46. Kirchner H, Tong J, Tschop MH & Pfluger PT 2010 Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants. American Journal of Physiology. Endocrinology and Metabolism 298 E909-E919. (doi:10.1152/ajpendo.00191.2009)
47. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 656-660. (doi:10.1038/45230)
48. Lann D & LeRoith D 2008 The role of endocrine insulin-like growth factor-I and insulin in breast cancer. Journal of Mammary Gland Biology and Neoplasia 13 371-379. (doi:10.1007/s10911-008-9100-x)
49. LeRoith D 2010 Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models. Diabetes/Metabolism Research and Reviews 26 599-601. (doi:10.1002/dmrr.1139)
50. Lim CT, Kola B & Korbonits M 2011 The ghrelin/GOAT/GHS-R system and energy metabolism. Reviews in Endocrine & Metabolic Disorders 12 173-186. (doi:10.1007/s11154-011-9169-1)
51. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(KDDC(T)) method. Methods 25 402-408. (doi:10.1006/meth.2001.1262)
52. Lu C, McFarland MS, Nesbitt RL, Williams AK, Chan S, Gomez-Lemus J, Autran AM, Al-Zahrani A, Chin JL, Izawa JI et al. 2012 Ghrelin receptor as a novel imaging target for prostatic neoplasms. Prostate 72 825-833. (doi:10.1002/pros.21484)
53. Lubik AA, Gunter JH, Hendy SC, Locke JA, Adomat HH, Thompson V, Herington A, Gleave ME, Pollak M & Nelson CC 2011 Insulin increases de novo steroidogenesis in prostate cancer cells. Cancer Research 71 5754-5764. (doi:10.1158/0008-5472.CAN-10-2470)
54. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM, Pollak M & Stampfer MJ 2008 Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncology 9 1039-1047. (doi:10.1016/S1470-2045(08)70235-3)
55. Malendowicz W, Ziolkowska A, Szyszka M & Kwias Z 2009 Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentrations in prostate carcinoma. Urologia Internationalis 83 471-475. (doi:10.1159/000251190)
56. Menghi F, Jacques TS, Barenco M, Schwalbe EC, Clifford SC, Hubank M & Ham J 2011 Genome-wide analysis of alternative splicing in medullo-blastoma identifies splicing patterns characteristic of normal cerebellar development. Cancer Research 71 2045-2055. (doi:10.1158/0008-5472. CAN-10-2519)
57. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K & Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409 194-198. (doi:10.1038/35051587)
58. Nilsen TW & Graveley BR 2010 Expansion of the eukaryotic proteome by alternative splicing. Nature 463 457-463. (doi:10.1038/nature08909)
59. O'Brien RM & Granner DK 1996 Regulation of gene expression by insulin. Physiological Reviews 76 1109-1161.
60. Patterson M, Murphy KG, le Roux CW, Ghatei MA & Bloom SR 2005 Characterization of ghrelin-like immunoreactivity in human plasma. Journal of Clinical Endocrinology and Metabolism 90 2205-2211. (doi:10.1210/jc.2004-1641)
61. Pazos Y, Alvarez CJ, Camina JP & Casanueva FF 2007 Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 25 373-381. (doi:10.1080/08977190801889313)
62. Pazos Y, Alvarez CJ, Camina JP, Al-Massadi O, Seoane LM & Casanueva FF 2009Role of obestatin on growth hormone secretion: an in vitro approach. Biochemical and Biophysical Research Communications 390 1377-1381. (doi:10.1016/j.bbrc.2009.10.163)
63. Pemberton C, Wimalasena P, Yandle T, Soule S & Richards M 2003 C-terminal pro-ghrelin peptides are present in the human circulation. Biochemical and Biophysical Research Communications 310 567-573. (doi:10.1016/j.bbrc.2003.09.045)
64. Pollak M 2008 Targeting insulin and insulin-like growth factor signalling in oncology. Current Opinion in Pharmacology 8 384-392. (doi:10.1016/j.coph.2008.07.004)
65. Rahman FA, Aziz N & Coverley D 2010 Differential detection of alternatively spliced variants of Ciz1 in normal and cancer cells using a custom exon-junction microarray. BMC Cancer 10 482. (doi:10.1186/1471-2407-10-482)
66. Repaci A, Gambineri A, Pagotto U & Pasquali R 2011 Ghrelin and reproductive disorders. Molecular and Cellular Endocrinology 340 70-79. (doi:10.1016/j.mce.2011.02.022)
67. Rome S, Clement K, Rabasa-Lhoret R, Loizon E, Poitou C, Barsh GS, Riou JP, Laville M & Vidal H 2003 Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. Journal of Biological Chemistry 278 18063-18068. (doi:10.1074/jbc.M300293200)
68. Romero A, Kirchner H, Heppner K, Pfluger PT, Tschop MH & Nogueiras R 2010GOAT: the master switch for the ghrelin system? European Journal of Endocrinology 163 1-8. (doi:10.1530/EJE-10-0099)
69. Satou M, Nishi Y, Yoh J, Hattori Y & Sugimoto H 2010 Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 151 4765-4775. (doi:10.1210/en.2010-0412)
70. Scerif M, Goldstone AP & Korbonits M 2011 Ghrelin in obesity and endocrine diseases. Molecular and Cellular Endocrinology 340 15-25. (doi:10.1016/j.mce.2011.02.011)
71. Seim I, Collet C, Herington AC & Chopin LK 2007 Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts. BMC Genomics 8 298. (doi:10.1186/1471-2164-8-298)
72. Seim I, Herington AC & Chopin LK 2009 New insights into the molecular complexity of the ghrelin gene locus. Cytokine & Growth Factor Reviews 20 297-304. (doi:10.1016/j.cytogfr.2009.07.006)
73. Seim I, Josh P, Cunningham P, Herington A & Chopin L 2011a Ghrelin axis genes, peptides and receptors: recent findings and future challenges. Molecular and Cellular Endocrinology 340 3-9. (doi:10.1016/j.mce. 2011.05.002)
74. Seim I, Walpole C, Amorim L, Josh P, Herington A & Chopin L 2011b The expanding roles of the ghrelin-gene derived peptide obestatin in health and disease. Molecular and Cellular Endocrinology 340 111-117. (doi:10.1016/j.mce.2011.03.018)
75. Skotheim RI & Nees M 2007 Alternative splicing in cancer: noise, functional, or systematic? International Journal of Biochemistry & Cell Biology 39 1432-1449. (doi:10.1016/j.biocel.2007.02.016)
76. Smyth G 2005 Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor, pp 397-420. Eds. R Gentleman, V Carey, S Dudoit, R Irizarry, W Huber. New York: Springer
77. Steiger A, Dresler M, Schussler P & Kluge M 2011 Ghrelin in mental health, sleep, memory. Molecular and Cellular Endocrinology 340 88-96. (doi:10.1016/j.mce.2011.02.013)
78. Suissa S, Azoulay L, Dell'aniello S, Evans M, Vora J & Pollak M 2011 Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia 54 2254-2262. (doi:10.1007/s00125-011-2190-9)
79. Takahashi T, Ida T, Sato T, Nakashima Y, Nakamura Y, Tsuji A & Kojima M 2009 Production of n-octanoyl-modified ghrelin in cultured cells requires prohormone processing protease and ghrelin O-acyltransferase, as well as n-octanoic acid. Journal of Biochemistry 146 675-682. (doi:10.1093/jb/mvp112)
80. Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K & Matsukura S 2001 Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochemical and Biophysical Research Communications 281 1220-1225. (doi:10.1006/bbrc.2001.4518)
81. Ueberberg B, Unger N, Saeger W, Mann K & Petersenn S 2009 Expression of ghrelin and its receptor in human tissues. Hormone and Metabolic Research 41 814-821. (doi:10.1055/s-0029-1233462)
82. Ukkola O 2011 Ghrelin in type 2 diabetes mellitus and metabolic syndrome. Molecular and Cellular Endocrinology 340 26-28. (doi:10.1016/j.mce.2011.02.009)
83. Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH & Pollak M 2007 Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. Journal of the National Cancer Institute 99 1793-1800. (doi:10.1093/jnci/djm231)
84. Volante M, Rosas R, Ceppi P, Rapa I, Cassoni P, Wiedenmann B, Settanni F, Granata R & Papotti M 2009 Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. Journal of Pathology 218 458-466. (doi:10.1002/path.2551)
85. Wilson C 2011 Diabetes: long-term use of insulin glargine might increase the risk of breast cancer. Nature Reviews. Endocrinology 7 499. (doi:10.1038/nrendo.2011.112)
86. Wren A, Small C, Ward H, Murphy K, Dakin C, Taheri S, Kennedy A, Roberts G, Morgan D, Ghatei M et al. 2000 The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 4325-4328. (doi:10.1210/en.141.11.4325)
87. Yang J, Brown MS, Liang G, Grishin NV & Goldstein JL 2008 Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132 387-396. (doi:10.1016/ j.cell.2008.01.017)
88. Yeh A, Jeffery PL, Duncan RP, Herington A & Chopin L 2005 Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clinical Cancer Research 11 8295-8303. (doi:10.1158/1078-0432.CCR-05-0443)
89. Yi CX, Heppner K & Tschop MH 2011 Ghrelin in eating disorders. Molecular and Cellular Endocrinology 340 29-34. (doi:10.1016/ j.mce.2011.03.001)
90. Yi CX, Heppner KM, Kirchner H, Tong J, Bielohuby M, Gaylinn BD, Muller TD, Bartley E, Davis HW, Zhao Y et al. 2012 The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS ONE 7 e32100. (doi:10.1371/journal.pone. 0032100)
91. Yu SQ, Lai KP, Xia SJ, Chang HC, Chang C, Yeh S et al. 2009 The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian Journal of Andrology 11 39-48. (doi:10.1038/aja.2008.44)
92. Zhang J, Ren P-G, Avsian-Kretchmer O, Luo C-W, Raucg R, Klein C & Hsueh A 2005 Obestatin,apeptide encodedbytheghrelin gene, opposes ghrelin's effects on food intake. Science 310 996-999. (doi:10.1126/science. 1117255)
93. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL & Brown MS 2010 Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. PNAS 107 7467-7472. (doi:10.1073/ pnas.1002271107)